|
RC300-400
|
RC347 Post Breast Therapy Pain Syndrome
Back to the Table of Contents
- RC347.A8.1 - Post Breast Therapy Pain Syndrome: The Patient's Perspective
Alexandra Andrews, WM, David Bradley, Eileen Pichersky, BA - It
is estimated that between 10% and 30% of patients will suffer
persistent pain after breast surgery... it seems to be a more common
occurrence in axillary dissections or total mastectomies than in
breast-conserving surgeries
http://www.cancersupportivecare.com/mastectomypain.php
First appeared 2002-03-01; updated 2007-10-31 - RC347.M41.1 - Post Breast Therapy Pain Syndrome: The Physical Therapist's Perspective
Francine Manuel, RPT and Gerald Hirschberg, MD -
Early restoration of range of motion to the shoulder is important to
prevent a frozen shoulder or shoulder/hand syndrome. These two entities
can cause pain separate from the neurogenic syndromes resulting from
invasive node dissections. Physical therapy modalities can be used in
conjunction with medications to help alleviate post breast surgery pain
syndrome.
http://www.cancersupportivecare.com/physicalpain.php
First appeared 2002-10-19; updated 2007-10-31 - RC347.R57.1 - Talking to Your Medical Team About Post Breast Therapy Pain Syndrome (PBTPS)
Karen Ritchie, MD, Sarah Schorr, RN, Charles M. Dollbaum, MD, PhD, Alexandra Andrews, WM, Jean Chan, BA, MA, SEd, Robert A. Wascher, MD, FACS - Recognition of Post Breast Therapy Pain Syndrome
(PBTPS) by the medical profession is still in its early stages. PBTBS
is best treated as soon as possible, because it becomes chronic and
more resistant to effective treatment when diagnosis and initiation of
therapy is delayed. Many doctors are unaware of this problem because
they have little experience in making the diagnosis, and in treating
this syndrome. You may, therefore, need to take a somewhat proactive
approach to educate your doctor or healthcare team about this problem,
and to seek effective solutions from them.
http://www.cancersupportivecare.com/paintalk.php
First appeared 2003-03-02; updated 2007-09-01 - RC347.S95.1 - Post Breast Therapy Pain Syndrome (PBTPS)
Sabrina Selim, MD, Richard Shapiro MD, E. Shelley Hwang, MD and Ernest Rosenbaum, MD - Post Breast Therapy Pain Syndrome (PBTPS) depends on
the characteristics, duration and location of pain. It is defined as
typical neuropathic pain and associated symptoms numbness, dysesthesia,
edema, allodynia located in the chest wall, axilla, arm, or shoulder of
the surgical side, and persists beyond the typical 3 month healing
period.
http://www.cancersupportivecare.com/neuropathicpain.php
First appeared 2002-06-01; updated 2007-10-31 - RC347.W90.1 - Post Breast Therapy Pain Syndrome Information Handouts
Robert Wascher, MD, FACS, Ernest Rosenbaum, MD, Alexandra Andrews, WM, Charles M. Dollbaum,MD, PhD, Karen Ritchie, MD, Sarah Schorr, RN, BSN, Francine Manuel, RPT, Jean Chan, BA, MA, SEd, Richard Shapiro, MD -
Post Breast Therapy Pain Syndrome (PBTPS) remains an underreported-yet
often debilitating-consequence of breast cancer therapy. Because PBTPS
is not well understood by many physicians, breast cancer patients are
often not advised about this risk prior to surgery, or the risk may be
otherwise minimized. Subsequently, many patients unexpectedly
experience chronic pain and other serious sensory disturbances that
detract from their quality of life.
http://www.cancersupportivecare.com/pbtpsinfo.html
First appeared 2003-03-06; updated 2006-12-31 - RC347.W90.2 - Post Breast Therapy Pain Syndrome Information Handout Page 1
Robert Wascher, MD, FACS, Ernest Rosenbaum, MD, Alexandra Andrews, WM, Charles M. Dollbaum,MD, PhD, Karen Ritchie, MD, Sarah Schorr, RN, BSN, Francine Manuel, RPT, Jean Chan, BA, MA, SEd, Richard Shapiro, MD - Page 1 of Handout about Post Breast Therapy Pain Syndrome (PBTPS) in pdf
http://www.cancersupportivecare.com/pbtpspage1.pdf
First appeared 2003-03-06; updated 2007-04-02 - RC347.W90.3 - Post Breast Therapy Pain Syndrome Information Handout Page 2
Robert Wascher, MD, FACS, Ernest Rosenbaum, MD, Alexandra Andrews, WM, Charles M. Dollbaum,MD, PhD, Karen Ritchie, MD, Sarah Schorr, RN, BSN, Francine Manuel, RPT, Jean Chan, BA, MA, SEd, Richard Shapiro, MD - Page 2 of Handout about Post Breast Therapy Pain Syndrome (PBTPS) in pdf
http://www.cancersupportivecare.com/pbtpspage2.pdf
First appeared 2003-03-06; updated 2006-10-03 - RC347.W90.4 - Post Breast Therapy Pain Syndrome Information Handout
Robert Wascher, MD, FACS, Ernest Rosenbaum, MD, Alexandra Andrews, WM, Charles M. Dollbaum, MD, PhD, Karen Ritchie, MD, Sarah Schorr, RN, BSN, Francine Manuel, RPT, Jean Chan, BA, MA, SEd, Richard Shapiro, MD -
Post Breast Therapy Pain Syndrome remains an underreported-yet often
debilitating-consequence of breast cancer therapy. PBTPS is not well
understood by many physicians and breast cancer patients are often not
advised about this risk prior to surgery, or the risk may be otherwise
minimized.
http://www.cancersupportivecare.com/pbtpshandout.php
First appeared 2005-02-15; updated 2007-10-31 - RC347.W90.5 - Post Breast Therapy Pain Syndrome: A Surgeon's Perspective
Robert A. Wascher, MD, FACS - Additional factors linked to breast cancer-associated
chronic pain syndromes include polyneuropathies caused by chemotherapy
and radiation therapy, which may be additive to impairments caused by
surgery
http://www.cancersupportivecare.com/surgerypain.php
First appeared 2002-04-10 updated 2007-10-31 - RC347.W90.6 - Post-Breast Therapy Pain Syndrome and Lymphedema: A Web-based Approach to Patient & Physician Education on www.cancersupportivecare.com
Joint Women's Health-Breast Oncology Program Scientific Retreat on Early Detection and Interventions in Breast, Ovarian, and Cervical Cancers Poster Session 5:00-7:00 pm, Thursday, March 13, 2003
Robert A. Wascher, MD, FACS, Charles Dollbaum, MD, PhD, Alexandra Andrews, Richard Shapiro, MD, E. Shelley Hwang,MD, Jean Chan, Francine Manuel, RPT, Ernest H. Rosenbaum, MD - Post Breast Therapy Pain Syndrome (PBTPS) remains an underreported-yet often debilitating-consequence of breast cancer therapy. PBTPS is estimated to affect 10 to 30% of women who have had breast cancer surgery. Because PBTPS is not well understood by many physicians, breast cancer patients are often not advised about this risk prior to surgery, or the risk may be otherwise minimized. Subsequently, many patients unexpectedly experience chronic pain and other serious sensory disturbances that detract from their quality of life. In post-surgery follow-up visits, patients may describe some early postoperative pain, but often PBTPS does not manifest as an ongoing chronic problem until at least 30-90 days afterwards.
http://www.cancersupportivecare.com/ucsf2003.html
First appeared 2003-12-17 updated 2007-02-18 - RC347.W90.7 - Complications of breast cancer therapy, lymphedema and PBTPS
Abstract F-21 for the American Society of Breast Disease 31st Annual Symposium Society of Clinical Oncology, April 12-14, 2007, San Francisco, CA
Robert Wascher, MD1, Ernest H. Rosenbaum, MD2, Alexandra Andrews2, David Spiegel, MD2, Charles M. Dollbaum, MD, PhD3
1Division of Surgical Oncology, Newark Beth Israel Medical Center, Newark, NJ 07112, 2CancerSupportiveCare.com, Website, Stanford Hospitals and Clinics, Palo Alto, CA, United States, 94304 and 3Carol Franc Buck Breast Care Center, University of California San Francisco, San Francisco, CA, United States, 94115 - Complications of breast cancer therapy, and lymphedema and
PBTPS in particular, can result in a significantly adverse impact on quality of life (QOL) for millions of
breast cancer patients.
http://www.cancersupportivecare.com/asbdpbtps.html
First appeared 2007-07-02
RC358.5 Stroke
Back to the Table of Contents
- RC358.5.L185.1 - Stroke
Jay S. Luxenberg, MD and Ernest H. Rosenbaum, MD - A stroke is a highly treatable disease like a heart attack, but one must immediately get to a stroke center or hospital for early treatment. Due to delays, many are left with major physical debilities that totally change their lives. Signs of a stroke are sudden onset of dizziness, unsteadiness, a sudden fall, visual dimness, difficulty speaking or understanding speech, numbness, weakness in face, arms, legs
http://www.cancersupportivecare.com/Survivor/stroke.html
First appeared 2008-01-15; updated 2008-08-02
RC409 Neurology. Neuropathy
Back to the Table of Contents
- RC409.N4.1 - Neuropathy from Chemotherapy
Zoe Ngo, PharmD - Chemotherapy can have adverse effects on the nervous
system. Some chemotherapy such as vincristine, cisplatin, and
paclitaxel have been known to cause symptoms of neuropathy such as
numbness, tingling and pain in the extremities, mild weakness, and
constipation. Severe nerve damage may cause impaired walking abilities,
severe bladder dysfunction, and disabling sensory loss. These side
effects may improve or disappear after the discontinuation of
chemotherapy
http://www.cancersupportivecare.com/neuropathy.html
First appeared 2003-08-10 updated 2007-11-08 - RC409.W149.1 - Chemotherapy-induced Peripheral Neuropathy - CPIN Fact Sheet
Meredith A. Wampler, PT, DPTSc and Ernest H. Rosenbaum, MD -
Chemotherapy-induced peripheral neuropathy (CPIN) describes damage to the
peripheral nervous system and the rest of the body, caused by some
chemotherapy agents. Commonly used chemotherapy agents associated with
peripheral neuropathy are listed
http://www.cancersupportivecare.com/nervepain.php
First appeared 2005-10-28; updated 2008-04-02 - RC409.W149.2 - Chemotherapy-induced Peripheral Neuropathy Fact Sheet- References
Meredith A. Wampler, PT, DPTSc and Ernest H. Rosenbaum, MD -
References for Chemotherapy-induced peripheral neuropathy. Commonly used chemotherapy agents associated with peripheral neuropathy are listed
http://www.cancersupportivecare.com/nervepainref.html
First appeared 2005-10-28; updated 2007-07-18
Card Catalog Site Map | Site Index | Search CancerSupportiveCare.com | Contact Us | Books | Top
First appeared January 15, 2008; updated August 2, 2008
First appeared January 15, 2008; updated August 2, 2008